Expanding access to intravenous tissue-type plasminogen activator treatment with a practice-based telestroke system

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 8, 2013, Pages

  Sanders, Keith A ^a   Figiel, Christine ^a   Kiely, James M ^a   Gwynn, Matthews W ^a   Johnston, Lisa H ^a  

^a AcuteCare Telemedicine   (United States)

Author keywords

stroke mimic; telemedicine; telestroke; thrombolysis; Tissue type plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMOGRAPHY; EPILEPSY; FIBRINOLYTIC THERAPY; GLIOBLASTOMA; HEART DISEASE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; TELEMEDICINE; TELESTROKE SYSTEM; TREATMENT OUTCOME; AGE; COMPARATIVE STUDY; DISABILITY; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE DELIVERY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; STROKE; TELECONSULTATION; TIME; TIME TO TREATMENT; UNIVERSITY HOSPITAL; VERY ELDERLY;

ACADEMIC MEDICAL CENTERS; ADMINISTRATION, INTRAVENOUS; AGE FACTORS; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; HEALTH SERVICES ACCESSIBILITY; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REMOTE CONSULTATION; SEVERITY OF ILLNESS INDEX; STROKE; TELEMEDICINE; THROMBOLYTIC THERAPY; TIME FACTORS; TIME-TO-TREATMENT; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84889046859     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.06.013     Document Type: Article

References (11)

1. G.S. Silva, S. Farrell, and E. Shandra The status of telestroke in the United States: A survey of currently active stroke telemedicine programs Stroke 43 2012 2078 2085
2. S.F. Zaidi, M.A. Jumma, and X.N. Urra Telestroke-guided intravenous tissue-type plasminogen activator treatment achieves a similar clinical outcome as thrombolysis at a comprehensive stroke center Stroke 42 2011 3291 3293
3. H.J. Audebert, C. Kukla, and B. Vatankhah Comparison of tissue plasminogen activator administration management between telestroke network hospitals and academic stroke centers. The Telemedic Pilot Project for Integrative Stroke Care in Bavaria/Germany Stroke 37 2006 1822 1827
4. American Heart Association Web site. Stroke scale computer course. Available from: http://learn.heart.org/ihtml/application/student/interface. heart2/nihsscomputer.html. Accessed March 16, 2013.
5. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
6. G.W. Albers, V.E. Bates, and W.M. Clark Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study JAMA 283 2000 1145 1150
7. S. Schwab, B. Vatankhah, and C. Kukla Long-term outcome after thrombolysis in telemedical stroke care Neurology 69 2007 898 903
8. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics - 2012 update: A report from the American Heart Association Circulation 125 2012 e2 e220
9. G. Tsivgoulis, A.V. Alexandrov, and J. Chang Safety and outcomes of intravenous thrombolysis in stroke mimics: A 6-year, single-care center study and a pooled analysis of reported series Stroke 42 2011 1771 1774
10. S. Yaghi, S. Rayaz, and N. Bianchi Thrombolysis to stroke mimics in telestroke J Telemed Telecare 2012 Oct 3 [Epub ahead of print]
11. S.M. Lai, M. Alter, and G. Friday Disposition after acute stroke: Who is not sent home from hospital? Neuroepidemiology 17 1998 21 29